# Aura Biosciences, Inc.: Form 8-K, filed Mar 30, 2026

- Company: [Aura Biosciences, Inc.](/companies/aura.md) (CIK 1501796)
- Form: 8-K
- Filed: 2026-03-30
- Accepted by EDGAR: Mar 30, 2026, 07:05 ET
- Period: 2026-03-30
- Accession: 0001193125-26-130383
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501796/000119312526130383/aura-20260330.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501796/000119312526130383/

## Items reported

- Item 2.02: Results of operations
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501796/000119312526130383/aura-20260330.htm

Filed Mar 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-130383. Last ingested by Listed: Nov 14, 2026, 18:49 ET. No prices; not investment advice.
